Dr Krishnan Chakravarthy will be speaking at the SBMT 15th Annual Congress – Millennium Biltmore Hotel in LA in April.
The 15th Annual World Congress of SBMT will bring together physicians, scientists, policy makers, funding agencies and industry to further the advances and applications in brain and spinal cord mapping and image guided therapies (operative and non-operative). The conference will take place at the Millennium Biltmore Hotel in LA (April 13th to April 15th 2018) in the metropolitan city of Los Angeles, California on the West Coast of the United State of America.
We encourage you to come and visit the annual conference which will host a world class program across the three days, an exhibition hall, poster displays and plenty of networking events.
The conference aim is to create a critical mass by introducing synergy amongst inter-disciplinary researchers to further understand the brain function and nervous system. It will serve as a platform from which to develop interactions between many of the stakeholders who also have extensive collaborations at national and international levels.
The conference provides the opportunity to be at the forefront of brain sciences, therapeutics in general and neural stem cells interventions in particular. It provides a strong platform for industry and biotech companies to interact with academia in frontiers of science in this field for translational initiatives involving diverse patient’s interest groups.
The official language of this convention is English. Topics covered including:
- Neurosurgery (e.g. Image Guided Therapy/intervention, brain tumors and intraoperative navigation, nanoneurosurgery, stereotactic radiosurgery, minimally invasive therapy, vascular neurosurgery, functional neurosurgery, neurotrauma/military medicine, surgical simulation…)
- Neurology (e.g. Movement Disorders, Neurodegenerative Diseases, Neurooncology, Neuromodulation, epilepsy, autism, brain and spinal cord function…)
- Psychiatry (e.g. medical imaging for psychiatric conditions such as schizophrenia, depression, PTSD…)
- Radiology (e.g. fMRI, PET, Nuclear medicine, MR SPEC, MR-PET, DTI, CT-PET, Focused Ultrasound, SQUID MRI, ultra high/low MRI)
- Neuroscience (e.g. stem cell, molecular neuroscience, image guided mapping of genes, proteomics, genomics, neurophysiology,…)
- Neuroengineering (e.g. biomaterial & tissue engineering, human brain Machine Interface, brain and spinal cord devices, nanomedicine, extraterrestrial/space medicine & clinical practice, software engineering, electrical and material engineering, aeronautic engineering/space medicine and Radiation Physics/Oncology as well as robotics)
- Nano-Bio-Electronics (e.g. integration of Stem cell/cellular therapy with nanotechnology, medical devices and imaging)
- Spinal Cord (e.g. regeneration, stem cell, imaging, implants and biologics and imaging…)
- Policy (e.g. healthcare policy issues that affect the treatment delivery, and usage of certain devices/drugs/imaging technologies, FDA regulations and reimbursements, federal and regional regulation impacting healthcare delivery and research funding…)
The audience includes:
Neuroscientists, Neurosurgeons, Neurologists, radiologists, pathologists, Oncologists, Chemists, engineers (material, electrical, biomedical, aeronautics and computer), stem cell and molecular biologists, nanotechnologists, pharmacologists and rehabilitation medicine scientists and physicians, psychiatrists and psychologists. Undergraduate and graduate students are welcomed. The program also covers the great work done by post-doctoral candidates, fellows and world leaders in the field.
Krishnan Chakravarthy, MD, PhD is an assistant clinical professor who specializes in multi-modal pain management. As a pain management specialist, he evaluates, diagnoses and treats all forms of pain.
Dr Chakravarthy completed sub-specialty fellowship training in pain management at Massachusetts General Hospital/Harvard Medical School and residency training in anesthesiology at The Johns Hopkins Hospital in Baltimore, MD. He interned in general medicine at Griffin Hospital (Yale Affiliate) in Derby, Connecticut. He earned his MD, PhD degrees at Jacobs School of Medicine and Biomedical Sciences in Buffalo, NY.
Dr Chakravarthy’s research interests in pain medicine include incorporating new technology into advancing pain care. He is currently focusing on using nanotechnology as an novel system to develop new drug delivery and point of care device platforms to manage chronic pain. Dr Chakravarthy’s research interests also focus on the effect of anesthetics on host immunity. Prior to joining UCSD, he has served as a contractor at the US Centers for Disease Control and Prevention (CDC) where he researched host immunity to influenza virus as a way of developing novel therapeutic and vaccine strategies. His research work has been published in top journals including Anesthesiology, Proceedings of the National Academy of Sciences, and Pain Medicine. His research work has been also featured in Times of India, International Business Times, Futurity, NewsMedical and other national and international venues.
Dr Chakravarthy is also a founder of several biotechnology startup companies in the nanotechnology space, and new drug development focusing on commercializing paradigm-shifting technology in the field of infectious diseases, and chronic pain. He is an active entrepreneur and believes industry plays a critical role in seeing translational science make it to patients.
Dr Chakravarthy currently serves on the editorial board of several national and international peer reviewed journals, and committees on organizations such as the International Neuromodulation Society.